Literature DB >> 19965602

A role for inflammatory mediators in heterologous desensitization of CysLT1 receptor in human monocytes.

Valérie Capra1, Maria Rosa Accomazzo, Fabrizio Gardoni, Silvia Barbieri, G Enrico Rovati.   

Abstract

Cysteinyl-leukotrienes (cysteinyl-LT) are rapidly generated at sites of inflammation and, in addition to their role in asthma, rhinitis, and other immune disorders, are increasingly regarded as significant inflammatory factors in cancer, gastrointestinal, cardiovascular diseases. We recently demonstrated that in monocyte/macrophage-like U937 cells, extracellular nucleotides heterologously desensitize CysLT(1) receptor (CysLT(1)R)-induced Ca(2+) transients. Given that monocytes express a number of other inflammatory and chemoattractant receptors, this study was aimed at characterizing transregulation between these different stimuli. We demonstrate that in U937 cells and in primary human monocytes, a series of inflammatory mediators activating G(i)-coupled receptor (FPR1, BLT(1)) desensitize CysLT(1)R-induced Ca(2+) response unidirectionally through activation of PKC. Conversely, PAF-R, exclusively coupled to G(q), cross-desensitizes CysLT(1)R without the apparent involvement of any kinase. Interestingly, G(s)-coupled receptors (beta(2)AR, H(1/2)R, EP(2/4)R) are also able to desensitize CysLT(1)R response through activation of PKA. Heterologous desensitization seems to affect mostly the G(i)-mediated signaling of the CysLT(1)R. The hierarchy of desensitization among agonists may be important for leukocyte signal processing at the site of inflammation. Considering that monocytes/macrophages are likely to be the major source of cysteinyl-LT in many immunological and inflammatory processes, shedding light on how their receptors are regulated will certainly help to better understand the role of these cells in orchestrating this complex network of integrated signals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19965602      PMCID: PMC2853434          DOI: 10.1194/jlr.M003236

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  52 in total

Review 1.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

2.  CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation.

Authors:  Valérie Capra; Saula Ravasi; Maria Rosa Accomazzo; Simona Citro; Monica Grimoldi; Maria P Abbracchio; G Enrico Rovati
Journal:  J Cell Sci       Date:  2005-12-01       Impact factor: 5.285

Review 3.  Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis.

Authors:  Robin P Choudhury; Justin M Lee; David R Greaves
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2005-06

Review 4.  G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways.

Authors:  L A Selbie; S J Hill
Journal:  Trends Pharmacol Sci       Date:  1998-03       Impact factor: 14.819

5.  Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling.

Authors:  Snehal Naik; Charlotte K Billington; Rodolfo M Pascual; Deepak A Deshpande; Frank P Stefano; Trudy A Kohout; Delrae M Eckman; Jeffrey L Benovic; Raymond B Penn
Journal:  J Biol Chem       Date:  2004-12-07       Impact factor: 5.157

Review 6.  Leukotriene modifiers as potential therapeutics for cardiovascular disease.

Authors:  Colin D Funk
Journal:  Nat Rev Drug Discov       Date:  2005-08       Impact factor: 84.694

7.  Functional characterization of human cysteinyl leukotriene 1 receptor gene structure.

Authors:  Grzegorz Woszczek; Rafal Pawliczak; Hai-Yan Qi; Sahrudaya Nagineni; Sura Alsaaty; Carolea Logun; James H Shelhamer
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

8.  Cysteinyl leukotrienes induce monocyte chemoattractant protein 1 in human monocytes/macrophages.

Authors:  T Ichiyama; M Hasegawa; Y Ueno; H Makata; T Matsubara; S Furukawa
Journal:  Clin Exp Allergy       Date:  2005-09       Impact factor: 5.018

9.  Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthma.

Authors:  G Enrico Rovati; Michele Baroffio; Simona Citro; Lorenzo Brichetto; Saula Ravasi; Manlio Milanese; Emanuele Crimi; Vito Brusasco
Journal:  Respir Res       Date:  2006-07-28

10.  An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients.

Authors:  Bryan Heit; Samantha Tavener; Eko Raharjo; Paul Kubes
Journal:  J Cell Biol       Date:  2002-10-07       Impact factor: 10.539

View more
  4 in total

1.  Formyl Peptide Receptor-1 Blockade Prevents Receptor Regulation by Mitochondrial Danger-Associated Molecular Patterns and Preserves Neutrophil Function After Trauma.

Authors:  Kiyoshi Itagaki; Elzbieta Kaczmarek; Woon Yong Kwon; Li Chen; Barbora Vlková; Quanzhi Zhang; Ingred Riça; Michael B Yaffe; Yan Campbell; Michael F Marusich; Ji Ming Wang; Wang-Hua Gong; Ji-Liang Gao; Françoise Jung; Garry Douglas; Leo E Otterbein; Carl J Hauser
Journal:  Crit Care Med       Date:  2020-02       Impact factor: 7.598

2.  Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation.

Authors:  Nora A Barrett; James M Fernandez; Akiko Maekawa; Wei Xing; Li Li; Matthew W Parsons; K Frank Austen; Yoshihide Kanaoka
Journal:  J Immunol       Date:  2012-09-21       Impact factor: 5.422

3.  The role of water in activation mechanism of human N-formyl peptide receptor 1 (FPR1) based on molecular dynamics simulations.

Authors:  Shuguang Yuan; Umesh Ghoshdastider; Bartosz Trzaskowski; Dorota Latek; Aleksander Debinski; Wojciech Pulawski; Rongliang Wu; Volker Gerke; Slawomir Filipek
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

Review 4.  Cysteinyl leukotrienes and their receptors; emerging concepts.

Authors:  Yoshihide Kanaoka; Joshua A Boyce
Journal:  Allergy Asthma Immunol Res       Date:  2014-05-27       Impact factor: 5.764

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.